Ibrutinib for chronic lymphocytic leukemia: international experience from a named patient program.

Hillmen P, Diels J, Healy N, Iraqi W, Aschan J, Wildgust M

Open source

DOI: 10.3324/haematol.2017.178798
Published: 2018 May
Container: Haematologica
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2017.178798,
  title = {Ibrutinib for chronic lymphocytic leukemia: international experience from a named patient program.},
  author = {Hillmen P and Diels J and Healy N and Iraqi W and Aschan J and Wildgust M},
  year = {2018},
  journal = {Haematologica},
  doi = {10.3324/haematol.2017.178798},
  url = {https://doi.org/10.3324/haematol.2017.178798}
}

RIS

TY  - JOUR
TI  - Ibrutinib for chronic lymphocytic leukemia: international experience from a named patient program.
AU  - Hillmen P
AU  - Diels J
AU  - Healy N
AU  - Iraqi W
AU  - Aschan J
AU  - Wildgust M
PY  - 2018
JO  - Haematologica
DO  - 10.3324/haematol.2017.178798
UR  - https://doi.org/10.3324/haematol.2017.178798
ER  -

APA

P, H., J, D., N, H., W, I., J, A., & M, W. (2018). Ibrutinib for chronic lymphocytic leukemia: international experience from a named patient program.. Haematologica. https://doi.org/10.3324/haematol.2017.178798

Source records

pubmed · retrieved 2026-11-10T20:39:41.903Z
europe-pmc · retrieved 2026-11-10T20:39:41.908Z
doaj · retrieved 2026-11-10T20:39:41.908Z